Desfesoterodine

CAS No. 207679-81-0

Desfesoterodine ( PNU-200577; (R)-5-Hydroxymethyl Tolterodine )

Catalog No. M17424 CAS No. 207679-81-0

5-hydroxymethyl tolterodine (PNU 200577) is a new muscarinic receptor antagonist with Kb of 0.84 nM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 132 In Stock
10MG 205 In Stock
25MG 353 In Stock
50MG 520 In Stock
100MG 750 In Stock
500MG 1521 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Desfesoterodine
  • Note
    Research use only, not for human use.
  • Brief Description
    5-hydroxymethyl tolterodine (PNU 200577) is a new muscarinic receptor antagonist with Kb of 0.84 nM.
  • Description
    5-hydroxymethyl tolterodine (PNU 200577) is a new muscarinic receptor antagonist with Kb of 0.84 nM.
  • Synonyms
    PNU-200577; (R)-5-Hydroxymethyl Tolterodine
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    207679-81-0
  • Formula Weight
    341.49
  • Molecular Formula
    C22H31NO2
  • Purity
    98%
  • Solubility
    DMSO : ≥ 100 mg/mL; 292.83 mM
  • SMILES
    CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nilvebrant L, et al. Pharmacol Toxicol, 1997, 81(4), 169-172.
molnova catalog
related products
  • Bis(maltolato)oxovan...

    BMOV is a potent, reversible, competitive and orally active pan-PTP (protein tyrosine phosphatases)inhibitor with insulin-mimicking effects and anti-diabetic properties.

  • Talabostat mesylate

    Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation protein.

  • SHIP2-IN-1

    SHIP2-IN-1 is a potent SHIP2 inhibitor(IC50 : 2 μM),and used in the research of Alzheimer’s disease.